Filing Flows › Glaukos (GKOS) › Recalls, complaints & regulation
Glaukos (GKOS): clinical trials
Glaukos (GKOS) beyond its filings: 11 active clinical trials.
Glaukos' latest quarter
Glaukos, Q3 2026: revenue $211M (+58% year over year), operating margin 0.4%, net earnings $2.0M, operating cash flow $38.6M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Glaukos have?
11 active studies on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.